Proof points across real-time clinical evidence infrastructure.
Public evidence cards spanning recent sponsor-side execution, current AI-native product work, remote telemetry origins, publications, and video artifacts.
Lead evidence cards
The strongest evidence areas for the current professional story.
Real-Time Clinical Trial Safety Signal Detection Technology Acquired by Philips
Kevin’s technology supported real-time interventional clinical trials and telehealth clinical decision support systems from 2002–2012, including Baylor Research Institute islet cell transplantation safety-signal workflows.
Ultragenyx — Sr. Director, Digital Clinical Development
Regulated digital clinical development leadership including Rarify, a live clinical technology platform supporting primary endpoints in a global pivotal Phase III clinical trial in EMEA.
Ultragenyx Clinical Development Leadership
Global Development Operations context, OLT/SLT membership, Protocol Development Team representation, technology feasibility, operational risk mitigation, patient-centered UI/UX, and wearables/CGM SME scope.
Innovation Lab — Ultragenyx
Built and led a global digital clinical development Innovation Lab from zero to 54 people across engineering, QA, product, test, study management, logistics, and clinical operations support.
PatientStories.ai — Principal
AI-native product work translating patient narratives into structured, privacy-aware signals for patient-centered trial design, research planning, and real-world evidence.
Operational Telemetry for Clinical Trials
A practical framework for trusted signals, governed review loops, traceability, workflow fit, and earlier operational visibility.
Diabetech / GlucoMON / RCAP
Foundational proof for early remote patient telemetry, connected glucose data, patient-anywhere workflows, and artificial pancreas lineage.
NHS / Healthimo + Joe Solo
Video evidence spanning connected-care adoption and patient education storytelling.
Additional evidence
Supporting artifacts, publications, and historical materials.
BellSouth / AT&T Remote Diabetes Pilot
Visual proof for early active disease management, remote monitoring, and patient-anywhere participation.
LC-FAOD / DMP / Dojolvi Publication Evidence
Evidence for author credit and conference/publication trail connected to Ultragenyx disease monitoring work.
MediSelf Press / Sugar Surfing
Established publishing imprint behind patient education, storytelling, and expert collaboration.